Tyler-Stone Wealth Management’s Pfizer PFE Stock Holding History

Tyler-Stone Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$460	–	765
2024 Q2	$460	Hold	1	–	–	﹤0.01%	935
2024 Q1	$560	Buy	+1	New	+$28	﹤0.01%	918
2023 Q4	–	Sell	-1	Closed	-$1K	–	981
2023 Q3	$1K	Hold	1	–	–	﹤0.01%	878
2023 Q2	$1K	Buy	+1	New	+$39	﹤0.01%	860

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tyler-Stone Wealth Management's PFE Position: Q2 2025 in Review

Tyler-Stone Wealth Management reduced its Pfizer (PFE) stake by 2.5% in Q2 2025, selling an estimated $39.2K and leaving 64,772 shares worth $1.57M. The position accounts for 0.25% of the portfolio, ranked #77.

Tyler-Stone Wealth Management first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.18M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Tyler-Stone Wealth Management held 64,772 shares of Pfizer worth $1.57M as of Q2 2025.
Tyler-Stone Wealth Management sold 1,681 Pfizer shares in Q2 2025, an estimated $39.2K.
Pfizer made up 0.25% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #77 holding.
Tyler-Stone Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
Tyler-Stone Wealth Management's Pfizer position peaked at $3.18M in Q4 2021.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.